263 related articles for article (PubMed ID: 30950431)
1. Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005-2010.
Martin M; Vanichseni S; Leelawiwat W; Anekvorapong R; Raengsakulrach B; Cherdtrakulkiat T; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; McNicholl JM; Kittimunkong S; Curlin ME; Choopanya K;
WHO South East Asia J Public Health; 2019 Apr; 8(1):50-55. PubMed ID: 30950431
[TBL] [Abstract][Full Text] [Related]
2. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
[TBL] [Abstract][Full Text] [Related]
3. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data.
Palmateer NE; McAuley A; Dillon JF; McDonald S; Yeung A; Smith S; Barclay S; Hayes P; Shepherd SJ; Gunson RN; Goldberg DJ; Hickman M; Hutchinson SJ
Addiction; 2021 Oct; 116(10):2893-2907. PubMed ID: 33651446
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
6. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN
Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152
[TBL] [Abstract][Full Text] [Related]
7. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
Iversen J; Wand H; McManus H; Dore GJ; Maher L
Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
[TBL] [Abstract][Full Text] [Related]
8. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
[TBL] [Abstract][Full Text] [Related]
9. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
10. Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions.
Ti L; Kaplan K; Hayashi K; Suwannawong P; Wood E; Kerr T
J Public Health (Oxf); 2013 Dec; 35(4):578-84. PubMed ID: 23335599
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.
Kåberg M; Hammarberg A; Lidman C; Weiland O
Infect Dis (Lond); 2017 Oct; 49(10):728-736. PubMed ID: 28574295
[TBL] [Abstract][Full Text] [Related]
12. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
[TBL] [Abstract][Full Text] [Related]
13. Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs.
Opheim E; Dalgard O; Ulstein K; Sørli H; Backe Ø; Foshaug T; Couëssurel Wüsthoff LE; Midgard H
Int J Drug Policy; 2024 Jan; 123():104279. PubMed ID: 38061225
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
[TBL] [Abstract][Full Text] [Related]
15. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ
Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore.
Falade-Nwulia O; Hackman J; Mehta SH; McCormick SD; Kirk GD; Sulkowski M; Thomas D; Latkin C; Laeyendecker O; Ray SC
BMC Infect Dis; 2020 Nov; 20(1):815. PubMed ID: 33167892
[TBL] [Abstract][Full Text] [Related]
18. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
Elife; 2021 Aug; 10():. PubMed ID: 34342266
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
Yi S; Mun P; Chhoun P; Chann N; Tuot S; Mburu G
Harm Reduct J; 2019 Apr; 16(1):29. PubMed ID: 31036011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
